Cheryl Leyns is among the promising graduate students spread out across the School of Medicine. She works in David Holtzman’s lab, researching pathologies of Alzheimer’s disease. (Photo: James Byard)

A promising future

At Washington University, training the next generation of leaders in translational medicine is a key focus. Here, Cheryl Leyns and Phat Huynh share stories of working in the lab of David Holtzman, MD, researching pathologies of Alzheimer’s disease.
hand holding pills

Cutting NIH budget could cripple drug development

New research indicates that more than 90 percent of the newest and most widely prescribed drugs on the market needed National Institute of Health (NIH) funding early in their development. The researchers believe proposed cuts to the NIH budget could cripple future development of new, life-saving drugs.
doctors speak to each other

$6 million supports leukemia research

John F. DiPersio, MD, PhD, of Washington University School of Medicine in St. Louis, has received a $6 million outstanding investigator award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support research aimed at improving therapies for leukemia.